Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,243 | -2,071 | -806 | -3,273 | -2,479 |
| Depreciation Amortization | 7 | -5 | -2 | -22 | -23 |
| Other Working Capital | 133 | 148 | 25 | 184 | -54 |
| Other Operating Activity | 465 | 227 | 74 | 231 | 251 |
| Operating Cash Flow | $-2,638 | $-1,701 | $-710 | $-2,881 | $-2,305 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,385 | 2,000 |
| PPE Investments | -45 | N/A | N/A | -121 | -121 |
| Investing Cash Flow | $-45 | $N/A | $N/A | $1,263 | $1,879 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,150 | 3,850 | 3,850 | N/A | 140 |
| Debt Repayment | -139 | -94 | -47 | N/A | N/A |
| Common Stock Issued | 8,350 | N/A | N/A | 2 | N/A |
| Financing Cash Flow | $13,361 | $3,756 | $3,803 | $2 | $140 |
| Beginning Cash Position | 1,016 | 1,016 | 1,016 | 2,016 | 2,016 |
| End Cash Position | 11,695 | 3,072 | 4,109 | 401 | 1,730 |
| Net Cash Flow | $10,679 | $2,056 | $3,093 | $-1,616 | $-286 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,638 | -1,701 | -710 | -2,881 | -2,305 |
| Capital Expenditure | -45 | N/A | N/A | -121 | -121 |
| Free Cash Flow | -2,683 | -1,701 | -710 | -3,002 | -2,426 |